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Radiation inactivation analysis of the binding of the A, adenosine receptor antagonist, 8cyclopentyL1,3-dipropylxan- 
thine to rat brain membranes yielded a radiation inactivation size of 58 kDa. In the presence of GTPyS this was reduced 
to 33 kDa, in good agreement with the size of the ligand-binding subunit detected after photoaffinity labelling. The data 
indicate that the structural association of A, adenosine receptors with G-protein components is altered in situ in the 
presence of guanine nucleotides. 
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1. INTRODUCTION 
Adenosine is an important regulator of several 
biochemical and physiological processes in various 
tissues [ 11. The effects of this nucleoside are 
mediated by extracellular eceptors that have been 
classified into two groups, A1 and AZ, according to 
their pharmacological and biochemical charac- 
teristics. In the central nervous system, the modu- 
latory actions of adenosine on nerve cell activity 
are mediated via receptors of the Ai type [2,3]. The 
emerging importance of adenosine as a neuromo- 
dulator has led to several investigations of its 
mechanisms of action and to molecular studies of 
the Ai receptor. The determination of the 
molecular size of the receptor has been approached 
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using several methods. In particular, photoaffinity 
labelling using several agonist and antagonist 
radioligands has shown that the ligand-binding 
polypeptide has an apparent molecular mass of ap- 
prox. 35 kDa [4-61. 
A further strategy for determining apparent 
molecular size is by the radiation inactivation 
technique, otherwise known as target size analysis 
[7]. The loss of biological activity, e.g. ligand- 
receptor binding, with increasing doses of ionising 
radiation allows determination of the radiation in- 
activation size (RIS). In addition, if destruction of 
a polypeptide can be monitored directly, this 
method gives a second structural parameter, the 
target size, which may or may not be equal to the 
functionally determined RIS [8]. This method has 
provided important information on the molecular 
sizes of several hormone and neurotransmitter 
receptors [9]. 
Recently, the RIS of the Ai adenosine receptor 
was determined using the agonist ligand, R- 
[3H]phenylisopropyladenosine [lo]. The high- 
affinity binding site for this ligand was estimated 
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to be 63 kDa. Due to the apparent discrepancy be- 
tween this result and that obtained using photoaf- 
finity labelling techniques, together with recent 
observations indicating a different RIS for the 
agonist- and antagonist-binding sites for the Di- 
and Dz-dopamine receptors [ 11,121, we have re- 
examined the RIS of the Ai adenosine receptor in 
rat brain membranes using the recently developed, 
high-affinity antagonist ligand, 8-[3H]cyclopentyl- 
1,3_dipropylxanthine ([3H]DPCPX) [13,14]. The 
use of this antagonist has the advantage that bind- 
ing appears to be largely independent of an interac- 
tion with the guanine nucleotide binding protein, 
Gi, thus allowing determination of the size of the 
target corresponding to the receptor alone. 
2. MATERIALS AND METHODS 
Experiments were performed using a crude, post-nuclear 
pellet from rat cerebral cortex, prepared as in [2]. The mem- 
branes were finally suspended in ice-cold 50 mM Tris-HCl (PH 
7.4), at a concentration of 1 mg protein/ml. Where used, 
GTPyS was added 5 min before freezing to give a final concen- 
tration of 100 PM. Aliquots (5 ml) were frozen in solid CO2 in 
aluminium pots and irradiated for various times with 2.5 MeV 
electrons generated by a Van der Graaf generator at the GSF, 
Munich, at - 70°C exactly as described [15]. After irradiation 
samples were kept in solid CO2 until assaying for ligand binding 
activity. The dosimetry calibration of the irradiation system 
used in this study has been described [15]. 
Binding of the antagonist, [‘HIDPCPX, to irradiated mem- 
branes was measured as in [14] at a protein concentration of 
0.1 mg/ml. Saturation curves were obtained at ligand concen- 
trations within the range 0.05-5 nM. Data were analysed using 
the curve-fitting program, LIGAND [16], to yield the & and 
B,, values. In all cases the best fit was observed with a one-site 
binding model. 
Photoaffinlty labelling of membranes was performed accor- 
ding to [6] using the photolabile agonist ligand, [‘*‘I]AHPIA. 
Labelled membranes were irradiated at 0.2 mg/ml in the 
presence of 1 mg/ml bovine serum albumin. After irradiation, 
membranes were recovered by centrifugation at 100000 x g for 
1 h, dissolved in sample buffer and subjected to SDS- 
polyacrylamide gel electrophoresis. The 1251-labelled AI recep- 
tor band was excised and radioactivity determined in a gamma 
counter. The radioactivity in each band was expressed as a 
percentage of that in a frozen but unirradiated sample for con- 
structing inactivation plots. 
Acetylcholinesterase was determined radiometrically [ 171 and 
protein by the method of Lowry et al. 1181. 
The inactivation profiles obtained by plotting ln(% control) 
vs radiation dose were linear in all cases reported here. RIS was 
calculated using the empirical formula: 6.4 xlO”/Drr where 
037 is the dose (in rad) at which 37qo of the control binding re- 
mains [19]. Since this relationship was originally derived at 
room temperature, a further empirical factor of two was 
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employed to allow for the sensitivity of protein inactivation to 
temperature [20]. 
3. RESULTS 
Irradiation of membranes from rat brain led to 
a decrease in the B,, values for [‘HIDPCPX bin- 
ding (fig.lA). No significant effect was observed 
on binding affinity, Kd values being in the range 
0.3-0.6 nM with no clear trend on increase in ir- 
radiation dose. Incubation in the presence of 
GTPyS led to reduction in the sensitivity of 
[3H]DPCPX-binding sites to irradiation (fig.lA) 
and therefore a decrease in RIS. The RIS values 
calculated in the absence and presence of GTPyS 
were 58 + 2.5 and 33 -t 3 kDa, respectively. Direct 
measurement of the loss of previously 
photoaffinity-labelled receptor gave a target size of 
35 & 2 kDa (fig.lB). The endogenous 
acetylcholinesterase of cerebral membranes had an 
RIS of 62 rfr 2.5 kDa, in good agreement with 
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Fig. 1. Inactivation profiles of (A) [‘HIDPCPX-binding sites in 
the absence (A) or presence (0) of 100 FM GTPyS (Bmax values 
derived from saturation analysis) and (B) photoafflnity-labelled 
cerebral membranes. Membranes were irradiated for different 
times to give the total doses shown. 
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previously reported values of 61 kDa [15] and 
65 kDa [21]. 
4. DISCUSSION 
The RIS of -58 kDa for the antagonist-binding 
component of the cerebral A1 adenosine receptor 
found here is in good agreement with the value of 
63 kDa reported by Frame et al. [lo] for the high- 
affinity agonist-binding state as measured in the 
presence of Mg’+. 
Analysis of receptor structure using agonist 
radioligands has been complicated by two factors. 
Firstly, addition of GTP or its analogues to con- 
vert the receptor into the low-affinity agonist- 
binding state results in the loss of agonist binding 
and consequently greater errors in determining 
binding at higher irradiation doses. Secondly, at- 
tempts to determine the low-affinity state after 
saturation analysis of agonist-binding curves [22] 
or RIS analysis of cerebral membranes in the 
absence of exogenous Mg2+ [23] result in non- 
linear radiation inactivation profiles, with an in- 
crease in agonist binding occurring at low doses. 
These difficulties could be overcome in the present 
study by using a high-affinity antagonist 
radioligand, [‘HIDPCPX, which does not 
distinguish between the agonist high- and low- 
affinity states [14]. Thus, [3H]DPCPX binding 
could readily be measured in the presence of the 
GTP analogue, GTPyS. Under these conditions, 
the RIS estimated for the antagonist-binding com- 
ponent was found to decrease from 58 kDa for 
contr’ol membranes to 33 kDa, which is in excellent 
agreement with the value of approx. 35 kDa for 
the ligand-binding polypeptide determined after 
SDS-polyacrylamide gel electrophoresis [4-61. 
The reduction in RIS for [3H]DPCPX binding in 
the presence of GTPyS indicates the dissociation 
of a G-protein such as Gi from the ligand-binding 
component and provides a structural analogy to 
the changes in agonist affinity observed in the 
presence of guanine nucleotides in binding studies 
[24]. The difference in RIS of about 25 kDa in the 
presence and absence of GTPyS is, however, insuf- 
ficient to allow identification of the associated G- 
protein subunit. Indeed, caution should be exercis- 
ed when interpreting RIS data in terms of 
molecular structure. As discussed by Beauregard et 
al. [8] the original interpretation of target size was 
based upon the assumption that a single ionisation 
results in the physical breakdown of a protein with 
consequent loss of its biological activity. In the 
case of oligomeric proteins, however, examples 
have been found where a differential loss of 
specific functional domains occurs, resulting in 
RIS values less than the size of the polypeptide 
[25,26]. The 25 kDa difference in RIS observed in 
this study may therefore be an underestimate of 
the true molecular size of the associated compo- 
nent. On this assumption, either the (Y- or fl- 
subunit or the ,&y complex of the associated G- 
protein could account for the 25 kDa difference in 
RIS after GTPyS treatment. 
A further complication in the interpretation of 
the RIS in terms of a radiation-induced breakdown 
of protein structure is revealed by the data obtain- 
ed with the covalent agonist-receptor complex. Ir- 
radiation of photoaffinity-labelled membranes 
yielded a target size of 35 kDa based upon the 
destruction of a 35 kDa 1251-labelled band after 
polyacrylamide gel electrophoresis. This coin- 
cidence between the target size and the elec- 
trophoretically derived molecular size indicates 
that loss of the 35 kDa ligand-binding component 
occurs independently of the transfer of destructive 
energy from the associated G-proteins which 
would lead to a greater target size. On the other 
hand, measurement of the loss of [3H]DPCPX bin- 
ding activity in the absence of GTPyS yielded an 
RIS of 53 kDa. Since the membranes were ir- 
radiated in the absence of adenosine deaminase 
and the Ai receptors were therefore presumably 
occupied by endogenous adenosine, it seems 
reasonable to suppose that, as in the case of the 
covalent agonist-receptor complex, no destructive 
energy transfer occurred from G-protein to recep- 
tor. This would seem to indicate, as suggested by 
Venter [9], that changes in tertiary structure of the 
receptor as a result of destruction of the G-protein 
might be sufficient to influence the RIS based 
upon measurement of biological activity. 
In conclusion, the reduction of the RIS for 
[3H]DPCPX binding in the presence of GTPyS 
strongly suggests the structural association of Ai 
adenosine receptors with G-protein components in 
brain membranes in situ. The nature of the G- 
protein subunit cannot be inferred from the 
GTPyS-induced shift in RIS. On the basis of cur- 
rent models of receptor-G protein interactions, the 
127 
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association with an a-subunit seems most likely 
[27]. However, solely on consideration of the RIS 
values, the possibility of the P-subunit being in- 
volved cannot be ruled out. Clearly, however, in- 
cubation of brain membranes with guanine 
nucleotide leads to changes in the structure and 
function of the Ar-receptor/G-protein complex. 
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